ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Prognostication and likelihood ratios: methodology, discrimination, and interpretation - a clinician's guide to prognostic tools.
Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrognostication is fundamental to clinical decision-making in palliative medicine, yet most clinicians report inadequate training and rarely use validated prognostic tools in practice. A critical barrier is limited understanding of statistical performance metrics, particularly likelihood ratios (LRs), which quantify a tool's discriminative ability and clinical utility for individual patients.
objectiveTo review the statistical methodology underlying prognostic tools, with emphasis on likelihood ratios, and to provide clinicians with a framework for critically assessing and interpreting published prognostic models.
methodsThe primary publications contributing to Table 1 were reviewed to verify the study population, prediction horizon, model or threshold, outcome direction, sensitivity, and specificity for each operating point. The quantitative analysis included 27 model-threshold-horizon combinations with verifiable sensitivity and specificity. Positive likelihood ratio (PLR), negative likelihood ratio (NLR), Weissler negative likelihood ratio (wNLR), diagnostic odds ratio (DOR), and log10 transformations were calculated. Likelihood ratio isopleths were plotted in receiver operating characteristic (ROC) space. Studies reporting only area under the curve (AUC), hazard ratios, or risk-group survival were summarized descriptively rather than included in the ROC space analyses.
resultsThe 27 operating points showed substantial variation in likelihood ratios across tools, settings, prediction horizons, and thresholds. Nine operating points met both PLR ≥ 2 and NLR ≤ 0.5, eight met the PLR criterion alone, nine met the NLR criterion alone, and one met neither criterion. Selected PPI, PaP, and D-PaP thresholds provided the strongest short-term mortality discrimination. The Surprise Question and NECPAL showed high sensitivity but lower specificity, consistent with screening rather than definitive mortality classification. DOR was strong for 1 operating point, good for 6, moderate for 19, and minimal for 1.
conclusionsLikelihood ratios bridge population-level discrimination and patient-specific prognostic assessment. Prognostic performance was heterogeneous and often asymmetric: selected short-horizon PPI, PaP, and D-PaP thresholds provided stronger mortality discrimination, whereas the Surprise Question and NECPAL primarily supported screening. Prognostic tools should supplement rather than replace clinical judgment.
Indexed as
Identifiers
42911276What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.